Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 12:20:27 19/09/2024 BST			5-day change	1st Jan Change
28.68 ^EUR	+2.72%		+7.63%	-14.26%

07:40am	Trinity Biotech to Launch Indian Market Study for Glucose Monitoring Project with Bayer	MT
09-18	Trinity Biotech plc to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer	CI

BAYER AG : JP Morgan sticks Neutral

August 05, 2024 at 11:30 am

In a research note, JP Morgan analyst Richard Vosser has maintained his recommendation on the stock with a Neutral rating. The target price remains set at EUR 34.

Latest news about Bayer AG

Trinity Biotech to Launch Indian Market Study for Glucose Monitoring Project with Bayer	06:40am	MT
Trinity Biotech plc to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer	09-18	CI
BAYER AG : Jefferies gives a Neutral rating	09-18	ZD
Bayer: results for prostate cancer treatment	09-16	CF
BAYER AG : JP Morgan reiterates its Neutral rating	09-16	ZD
Bayer's Prostrate Cancer Therapy Cuts Risk of Radiological Progression, Death in Late-stage Trial	09-16	MT
RTW Biotech half-year net asset value rises amid "challenging markets"	09-13	AN
German Shares Advance as ECB Delivers Widely Expected Rate Cut	09-12	MT
Bayer wins another glyphosate lawsuit in the USA	09-12	DP
Bayer's Monsanto Secures Favorable Verdict in Roundup Weedkiller Philadelphia Trial	09-12	MT
Jury rules in favor of Bayer's Monsanto in Philadelphia trial over Roundup	09-12	RE
Bayer to present results from AMD trials	09-11	CF
Agrochemicals group Syngenta cuts jobs in Basel	09-11	RE
Bayer falls in recovered market environment - glyphosate remains in focus	09-11	DP
Bayer wants to take glyphosate lawsuits to the highest US court	09-11	RE
Goldman rates Bayer at 'Neutral' - Target 30 euros	09-10	DP
BAYER AG : Goldman Sachs remains Neutral	09-10	ZD
Study: Agriculture could significantly reduce greenhouse gases	09-10	DP
Bayer's Finerenone Cuts Risk of New-onset Diabetes in Late-stage Trial	09-10	MT
Bayer's OcuClick Secures Approval from European Medicines Agency	09-09	MT
BAYER AG : UBS sticks Neutral	09-09	ZD
Bayer: receives EMA approval	09-09	CF
Bayer: last-minute presentations at ESMO congress	09-06	CF
Veeva Systems: leader in cloud solutions for the life sciences industry	09-06
Bayer's bottoming out continues to take shape - BofA commentary	09-06	DP

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).

Employees

96,567

Sector

Pharmaceuticals

Calendar

05/11/2024 - Q3 2024 Earnings Release

More about the company